iShares Trust - iShares Future Exponential Technologies ETF (XT) Hisse Özeti
iShares Trust - iShares Future Exponential Technologies ETF, BlackRock, Inc. tarafından piyasaya sürülen bir borsa yatırım fonudur. Daha fazla detay
| Kar Tanesi Skoru | |
|---|---|
| Değerleme | 0/6 |
| Gelecekteki Büyüme | 0/6 |
| Geçmiş Performans | 0/6 |
| Finansal Sağlık | 0/6 |
| Temettüler | 2/6 |
XT Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
iShares Trust - iShares Future Exponential Technologies ETF Rakipler
Fiyat Geçmişi ve Performans
| Tarihsel hisse senedi fiyatları | |
|---|---|
| Güncel Hisse Fiyatı | US$82.28 |
| 52 Haftanın En Yüksek Seviyesi | US$84.23 |
| 52 Haftanın En Düşük Seviyesi | US$62.03 |
| Beta | 0 |
| 1 Aylık Değişim | 3.99% |
| 3 Aylık Değişim | 19.33% |
| 1 Yıllık Değişim | 30.79% |
| 3 Yıllık Değişim | 48.38% |
| 5 Yıllık Değişim | 31.94% |
| Halka arzdan bu yana değişim | 219.53% |
Son Haberler & Güncellemeler
XT: More Sensitive Than General Market To Cost Of Capital Changes
Summary The iShares Future Exponential Technologies ETF is highly sensitive to cost of capital shifts, driven by its tech and disruptor focus, also with a lot of high-multiple healthcare. XT's global diversification does not mitigate its vulnerability to rising rates and geopolitical risks, especially from the Iran conflict, which is having a global upward cost of capital shift effect. XT is less concentrated in mega-cap US tech than IVV, but its higher IT and healthcare exposure increases sensitivity to inflation and capital costs and maintains sensitivity to overbuild risks. We see more risks than supports for XT, given fragile geopolitics and amplified yield curve sensitivity. Lower multiple alternatives in equity markets often present less cost of capital sensitivity. Read the full article on Seeking AlphaXT: An Undervalued Portfolio Of Innovative Global Tech Stocks
Summary iShares Exponential Technologies ETF focuses on companies driving technological innovation across various sectors, offering diversified exposure to high-growth potential industries. The ETF's investment thesis is centered on capturing the growth of exponential technologies, including AI, robotics, and biotechnology, which are expected to transform industries. The fund looks appealing due to its diversified portfolio, evidential capacity to out-perform (albeit not since January 2021), and alignment with long-term technological trends. At present, XT has clear potential for a high IRR, with the potential for returns of circa 11% annualized over the next five years. Read the full article on Seeking AlphaXT Will Likely Continue Lagging The Broader IT Sector
Summary iShares Exponential Technologies ETF is a hold due to multiple risk factors outweighing its returns along with a relatively high expense ratio. XT lacks holdings with strong fundamentals and diversified revenue streams compared to peer tech funds, particularly Vanguard's VGT. XT also includes foreign tech holdings in emerging markets, representing geopolitical risks. Read the full article on Seeking AlphaXT: Still Beating ARKK At Its Own Game, Upgrade To Buy For Possible Moonshot
Summary iShares Exponential Technologies ETF is a go-to holding due to market volatility and potential for high returns. I prefer XT to the ARK Innovation ETF, given its smoother path due to a more diversified and passive/indexed approach. XT's lower volatility and diversified portfolio make it a buy, with potential for a price increase to its 2022 high and beyond. Read the full article on Seeking AlphaXT: We're Going To Think Twice About This ETF
XT is pretty interesting and tackles an area of the market that has received flak in the latest sell-offs. However, we have some concerns about approaching emerging technologies with ETFs. Also the fund isn't that discounted despite expected reflexivity effects. Might get better bets with specific stocks. The iShares Exponential Technologies ETF (XT) might seem broadly interesting at first, but we have some misgivings about the concept of investing in ETFs of higher risk businesses. Moreover, we are surprised by how well the ETF has done all things considered, and worry that some latent effects might still hit it. Otherwise, we are pretty convinced of the appeal of tech in the current market, and feel that in general it should be studied by retail investors. But we would think twice about XT. Quick Breakdown First let's discuss some of the features of XT. The mandate is to build a portfolio that weights towards a decent amount of emerging markets and emerging technologies that follow nine key themes. XT Nine Areas of Focus (iShares.com) The themes listed above are pretty basic to be honest. We all know of the potential in these fields, and in the majority of cases the value of things like cloud computing have already been realised, at least in terms of priced in value, by large corporations through already profitable operations. Essentially, what XT is doing is allocating to all the sexiest ideas in investing that VCs would typically be focusing on. As mentioned it's not all US markets with only 62% allocation, which is nice because foreign markets typically don't value tech nearly as highly as the US does, and it's mostly tech but also some healthcare exposures, especially biotechs. The fee is below 0.5%, which isn't bad relative to some of these more 'exciting' ETFs. The fact sheet says that it's cheaper than 91% of ETFs in its category, but this should be taken with a grain of salt because they decide the categories. What matters is many iShares ETFs are around 0.4%, so just below 0.5% isn't bad relatively. ETFs and Exponential Technologies However, we have some comments about the ETF. The first is that the kinds of businesses it invests in, especially in healthcare, are stocks that depend reflexively on the equity capital market conditions. If their stocks decline, the cost of their financing rises. This is obviously bad because in unstable markets like the current one, where rates will have to rise a lot more to deal with inflation, because it causes vicious spirals.Recent updates
Hissedar Getirileri
| XT | US Capital Markets | US Pazar | |
|---|---|---|---|
| 7D | 2.3% | 4.1% | 2.2% |
| 1Y | 30.8% | 12.4% | 24.8% |
Getiri vs. Endüstri: XT geçen yıl % 12.4 oranında getiri sağlayan US Capital Markets sektörünü aştı.
Getiri vs Piyasa: XT geçen yıl % 24.8 oranında getiri sağlayan US Piyasasını aştı.
Fiyat Oynaklığı
| XT volatility | |
|---|---|
| XT Average Weekly Movement | 3.1% |
| Capital Markets Industry Average Movement | 3.5% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.1% |
İstikrarlı Hisse Senedi Fiyatı: XT son 3 ayda US piyasasına kıyasla önemli bir fiyat oynaklığı yaşamadı.
Zaman İçindeki Volatilite: XT 'nin haftalık oynaklığı ( 3% ) son bir yıldır istikrarlı seyretti.
Şirket Hakkında
| Kuruldu | Çalışanlar | CEO | Web sitesi |
|---|---|---|---|
| 2015 | n/a | n/a | www.ishares.com/us/products/272532/ishares-exponential-technologies-etf |
iShares Trust - iShares Future Exponential Technologies ETF, BlackRock, Inc. tarafından piyasaya sürülen bir borsa yatırım fonudur. Fon, BlackRock Fund Advisors tarafından yönetilmektedir. Fon, küresel bölgedeki halka açık hisse senedi piyasalarına yatırım yapar.
iShares Trust - iShares Future Exponential Technologies ETF Temel Bilgiler Özeti
| XT temel i̇stati̇sti̇kler | |
|---|---|
| Piyasa değeri | US$3.90b |
| Kazançlar(TTM) | US$0 |
| Gelir(TTM) | n/a |
XT aşırı değerli mi?
Gerçeğe Uygun Değer ve değerleme analizine bakınızKazanç ve Gelir
| XT gelir tablosu (TTM) | |
|---|---|
| Gelir | US$0 |
| Gelir Maliyeti | US$0 |
| Brüt Kâr | US$0 |
| Diğer Giderler | US$0 |
| Kazançlar | US$0 |
Son Raporlanan Kazançlar
n/a
Sonraki Kazanç Tarihi
n/a
| Hisse başına kazanç (EPS) | 0 |
| Brüt Marj | 0.00% |
| Net Kâr Marjı | 0.00% |
| Borç/Özkaynak Oranı | 0.0% |
XT uzun vadede nasıl bir performans gösterdi?
Geçmiş performansı ve karşılaştırmayı görünTemettüler
Şirket Analizi ve Finansal Veri Durumu
| Veri | Son Güncelleme (UTC saati) |
|---|---|
| Şirket Analizi | 2026/06/16 08:49 |
| Gün Sonu Hisse Fiyatı | 2026/06/15 00:00 |
| Kazançlar | N/A |
| Yıllık Kazançlar | N/A |
Veri Kaynakları
Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.
| Paket | Veri | Zaman Çerçevesi | Örnek ABD Kaynağı * |
|---|---|---|---|
| Şirket Finansalları | 10 yıl |
| |
| Analist Konsensüs Tahminleri | +3 yıl |
|
|
| Piyasa Fiyatları | 30 yıl |
| |
| Sahiplik | 10 yıl |
| |
| Yönetim | 10 yıl |
| |
| Önemli Gelişmeler | 10 yıl |
|
* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.
Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.
Analiz Modeli ve Kar Tanesi
Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına GitHub sayfamızdan ulaşabilirsiniz, ayrıca raporlarımızı nasıl kullanacağınızı anlatan kılavuzlarımız ve Youtube'da eğitim videolarımız da bulunmaktadır.
Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.
Endüstri ve Sektör Metrikleri
Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.
Analist Kaynakları
iShares Trust - iShares Future Exponential Technologies ETF 0 Bu analistlerden 0, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.